{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:06:07Z","timestamp":1790665567434,"version":"4.1.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We investigated the clinicopathologic features of 5 follicular lymphomas (FLs) that transformed (tFL) morphologically to diffuse large B-cell lymphomas (DLBCLs) and had a primary mediastinal large B-cell lymphoma (PMBL)\u2013like gene expression profile (tFL-PMBLsig-pos). None of the tFL-PMBLsig-pos cases arose in the mediastinum, all cases tested had a germinal center B-cell phenotype, 20% were CD30+, 60% CD23+, 80% MAL+, 20% CD200+, and 0% CD273\/PDL2+. Whole-exome sequencing detected alterations in genes associated with both FL\/DLBCL (CREBBP, KMT2C, KMT2D, ARID1A, HIST1 members, and TNFRSF14) and PMBL (JAK-STAT pathway genes, B2M, and CD58). Copy number (CN) analysis detected gains\/amplification of REL and STAT6 in 60%, gains of SOCS1 in 40%, and gains of chromosome 16, including IL4R, in 40% of the cases. CN gains\/amplification of BCL6 and MYC and loss of TNFRSF14 and TNFAIP3 were identified in 20% of the cases. Three of 5 cases lacked a BCL2 rearrangement. Despite having some features that are less common in DLBCL (MAL and CD23 expression and JAK-STAT activation), these tFL-PMBLsig-pos cases lack the most characteristic CN alteration seen in PMBL (9p24.1 gain\/amplification). This cohort expands the biologic heterogeneity of tFL, illustrating a subset with gene expression and some genetic features reminiscent of PMBL, with potential treatment implications that include the use of novel targeted therapies.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007360","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T18:15:18Z","timestamp":1665771318000},"page":"893-899","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Transformation of FL into DLBCL with a PMBL gene expression signature"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-3302","authenticated-orcid":false,"given":"Tristan","family":"Loveday","sequence":"first","affiliation":[{"name":"1Alix School of Medicine, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben","family":"Duns","sequence":"additional","affiliation":[{"name":"2Centre for Lymphoid Cancer, British Columbia (BC) Cancer, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1268-2750","authenticated-orcid":false,"given":"Lisa M.","family":"Rimsza","sequence":"additional","affiliation":[{"name":"3Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6770-2339","authenticated-orcid":false,"given":"Karen L.","family":"Rech","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-8085","authenticated-orcid":false,"given":"James R.","family":"Cook","sequence":"additional","affiliation":[{"name":"5Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Robetorye","sequence":"additional","affiliation":[{"name":"3Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-3163","authenticated-orcid":false,"given":"Allison C.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"6Division of Hematology\/Medical Oncology, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-7712","authenticated-orcid":false,"given":"Colleen A.","family":"Ramsower","sequence":"additional","affiliation":[{"name":"7Department of Research, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tameson K.","family":"Yip","sequence":"additional","affiliation":[{"name":"3Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"McKinney","sequence":"additional","affiliation":[{"name":"7Department of Research, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3832-3329","authenticated-orcid":false,"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"8Division of Hematopathology, University of Pittsburgh School of Medicine\/UPMC, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-2154","authenticated-orcid":false,"given":"Shweta","family":"Bhavsar","sequence":"additional","affiliation":[{"name":"5Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"},{"name":"8Division of Hematopathology, University of Pittsburgh School of Medicine\/UPMC, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-9750","authenticated-orcid":false,"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"name":"2Centre for Lymphoid Cancer, British Columbia (BC) Cancer, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-6442","authenticated-orcid":false,"given":"Sarah E.","family":"Gibson","sequence":"additional","affiliation":[{"name":"3Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"issue":"11","key":"2023081516042514800_bib1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A\u00a0clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"7","key":"2023081516042514800_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"2023081516042514800_bib3","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (revised 4th edition)","year":"2017"},{"issue":"32","key":"2023081516042514800_bib4","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"2023081516042514800_bib5","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"2023081516042514800_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.humpath.2020.06.001","article-title":"Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases","volume":"102","author":"Maeshima","year":"2020","journal-title":"Hum Pathol"},{"issue":"12","key":"2023081516042514800_bib7","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for trans differentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"issue":"6769","key":"2023081516042514800_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"15","key":"2023081516042514800_bib9","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2023081516042514800_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.2020007683","article-title":"Characterization of DLBCL with a PMBL gene expression signature","volume":"138","author":"Duns","year":"2021","journal-title":"Blood"},{"issue":"22","key":"2023081516042514800_bib11","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2023081516042514800_bib12","first-page":"3","article-title":"Incorporation of digital gene expression profiling for cell-of-origin determination (Lymph2Cx testing) into the routine work-up of diffuse large B-cell lymphoma","volume":"12","author":"Robetorye","year":"2019","journal-title":"J\u00a0Hematop"},{"issue":"1","key":"2023081516042514800_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"21","key":"2023081516042514800_bib14","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2017-11-764365","article-title":"Critical influences on the pathogenesis of follicular lymphoma","volume":"131","author":"Kuppers","year":"2018","journal-title":"Blood"},{"issue":"10","key":"2023081516042514800_bib15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"issue":"46","key":"2023081516042514800_bib16","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1073\/pnas.1611228113","article-title":"Structural basis for DNA recognition by STAT6","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"28","key":"2023081516042514800_bib17","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1038\/sj.onc.1205537","article-title":"The tumor suppressor activity of SOCS-1","volume":"21","author":"Rottapel","year":"2002","journal-title":"Oncogene"},{"issue":"18","key":"2023081516042514800_bib18","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2023081516042514800_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41408-019-0233-5","article-title":"Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma","volume":"9","author":"Wang","year":"2019","journal-title":"Blood Cancer J"},{"issue":"4","key":"2023081516042514800_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"key":"2023081516042514800_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","article-title":"Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes","volume":"71","author":"Panjwani","year":"2018","journal-title":"Hum Pathol"},{"key":"2023081516042514800_bib22","author":"Rech","year":"\u00a02021"},{"issue":"2","key":"2023081516042514800_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000771","article-title":"Performance of a commercially available MAL antibody in the diagnosis of primary mediastinal large B-cell lymphoma","volume":"41","author":"Gentry","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2023081516042514800_bib24","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2023081516042514800_bib25","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/6\/893\/2071649\/blooda_adv-2022-007360-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/6\/893\/2071649\/blooda_adv-2022-007360-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T16:19:44Z","timestamp":1692116384000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/6\/893\/486786\/Transformation-of-FL-into-DLBCL-with-a-PMBL-gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,3,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007360","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]}}}